NSE · NOVARTIND
Novartis Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
No disclosed results available.
Shareholding
No shareholding disclosed.
Promoter holding trend
Each disclosed period, oldest to newest
Not enough history.
52-week position
Where the current price sits in its yearly band
The band spans 2.65× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
AI analysis
AI-generated · google/gemini-2.5-flashNovartis India Ltd. (500672) operates in the Pharmaceuticals sector. The company has a market capitalization of Rs 4196 Cr. Its shares are currently trading at a P/E ratio of 45.03 and a book value of Rs 331.23. The earnings per share (EPS) is Rs 37.74. The company reported a profit margin of 26.3%.
Positives
- +The company has a low debt-to-equity ratio of 0.01.
- +Promoter holding is 70.6769% as of June 30, 2026.
- +Net profit increased to Rs 100.9 Cr in Mar 2025 from Rs 85.19 Cr in Mar 2024.
- +The company has a positive profit margin of 26.3%.
Negatives
- −Annual revenue has declined to Rs 398.23 Cr in Mar 2025 from Rs 436.85 Cr in Mar 2023.
- −The 52-week high of Rs 1722.2 is significantly higher than the 52-week low of Rs 750, indicating price volatility.
- −No dividend yield was reported.
- −The number of shareholders has decreased from 44,652 in Dec 2016 to 36,502 in June 2026.
Financial performance
Novartis India Ltd. reported annual revenue of Rs 398.23 Cr in Mar 2025, which is a decrease from Rs 436.85 Cr in Mar 2023. Net profit for Mar 2025 was Rs 100.9 Cr, an increase from Rs 85.19 Cr in Mar 2024. The company's highest annual revenue in the last five years was Rs 436.85 Cr in Mar 2023. Quarterly revenue in Mar 2026 was Rs 90.55 Cr, while net profit was Rs 25.25 Cr.
Profitability & Returns
The company's profit margin stands at 26.3%. Return on equity (ROE) was 11.39% and return on capital employed (ROCE) was 15.94% for the latest fiscal year. The earnings per share (EPS) for Mar 2025 was Rs 40.87. Over the last five years, EPS has fluctuated, with a peak of Rs 41.86 in Mar 2023 and a low of Rs -1.51 in Mar 2022.
Balance Sheet
Novartis India Ltd. has a low debt-to-equity ratio of 0.01, indicating minimal reliance on borrowed funds. The book value per share is Rs 331.23. No dividend yield was reported for the company. The company's EBITDA for Mar 2025 was Rs 131.19 Cr.
Ownership & Pledges
As of June 30, 2026, promoters held 70.6769% of the shares. Public shareholding was 27.8043%. Domestic Institutional Investors (DII) held 1.3566% and Foreign Institutional Investors (FII) held 0.1622%. Total institutional holding was 1.5188%. No promoter shares were reported as pledged.
Regulatory & Surveillance
The company is not currently under any surveillance measures according to the provided data. The number of shareholders as of June 30, 2026, was 36,502. This number has generally decreased from 44,652 in Dec 2016.
Data as of — price: 2026-07-29 · financials: not disclosed · shareholding: not disclosed. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.